Prognostic factors after definitive radio(chemo)therapy of locally advanced head and neck cancer

Daniel Seidl, Stefan Janssen, Primoz Strojan, Amira Bajrovic, Steven E. Schild, Dirk Rades

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aim: To identify predictors of locoregional control (LRC) and overall survival (OS) after definitive radio(chemo)therapy for squamous cell carcinoma of the head and neck (SCCHN). Patients and Methods: Two hundred and seventy-five patients were evaluated; 261 patients received radiochemotherapy with 30-40 mg/m2 of cisplatin weekly, three courses of cisplatin 100 mg/m2, two courses of cisplatin 5×20 mg/m2 or two courses of cisplatin 5×20 mg/m2plus 5-fluorouracil. Ten characteristics were analyzed: Pre-radiotherapy hemoglobin, T-/N-category, Karnofsky performance-score (KPS), gender, age, chemotherapy type, tumor site, grading and radiation dose. Results: On multivariate analyses, hemoglobin 12-14 g/dl (p=0.040), lower T-category (p=0.010), lower N-category (p=0.042) and female gender (p=0.006) were predictive of LRC. Hemoglobin >12 g/dl (p=0.020), lower N-category (p<0.001), KPS ≥80 (p<0.001), female gender (p=0.024) and cisplatin 100 mg/m2 or 5×20 mg/m2 (p<0.001) were predictors of improved OS. Conclusion: Predictors of LRC and OS were identified that can improve personalization of treatment. Since chemotherapy type was associated with OS, studies comparing different regimens are warranted.

Original languageEnglish (US)
Pages (from-to)2523-2526
Number of pages4
JournalAnticancer Research
Volume36
Issue number5
StatePublished - 2016

Fingerprint

Head and Neck Neoplasms
Radio
Cisplatin
Survival
Hemoglobins
Therapeutics
Drug Therapy
Neoplasm Grading
Chemoradiotherapy
Fluorouracil
Radiotherapy
Multivariate Analysis
Radiation

Keywords

  • Definitive radio(chemo) therapy
  • Locally advanced SCCHN
  • Locoregional control
  • Overall survival
  • Prognostic factors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Seidl, D., Janssen, S., Strojan, P., Bajrovic, A., Schild, S. E., & Rades, D. (2016). Prognostic factors after definitive radio(chemo)therapy of locally advanced head and neck cancer. Anticancer Research, 36(5), 2523-2526.

Prognostic factors after definitive radio(chemo)therapy of locally advanced head and neck cancer. / Seidl, Daniel; Janssen, Stefan; Strojan, Primoz; Bajrovic, Amira; Schild, Steven E.; Rades, Dirk.

In: Anticancer Research, Vol. 36, No. 5, 2016, p. 2523-2526.

Research output: Contribution to journalArticle

Seidl, D, Janssen, S, Strojan, P, Bajrovic, A, Schild, SE & Rades, D 2016, 'Prognostic factors after definitive radio(chemo)therapy of locally advanced head and neck cancer', Anticancer Research, vol. 36, no. 5, pp. 2523-2526.
Seidl D, Janssen S, Strojan P, Bajrovic A, Schild SE, Rades D. Prognostic factors after definitive radio(chemo)therapy of locally advanced head and neck cancer. Anticancer Research. 2016;36(5):2523-2526.
Seidl, Daniel ; Janssen, Stefan ; Strojan, Primoz ; Bajrovic, Amira ; Schild, Steven E. ; Rades, Dirk. / Prognostic factors after definitive radio(chemo)therapy of locally advanced head and neck cancer. In: Anticancer Research. 2016 ; Vol. 36, No. 5. pp. 2523-2526.
@article{61ba9deb9439436a858186e4da0ccf44,
title = "Prognostic factors after definitive radio(chemo)therapy of locally advanced head and neck cancer",
abstract = "Aim: To identify predictors of locoregional control (LRC) and overall survival (OS) after definitive radio(chemo)therapy for squamous cell carcinoma of the head and neck (SCCHN). Patients and Methods: Two hundred and seventy-five patients were evaluated; 261 patients received radiochemotherapy with 30-40 mg/m2 of cisplatin weekly, three courses of cisplatin 100 mg/m2, two courses of cisplatin 5×20 mg/m2 or two courses of cisplatin 5×20 mg/m2plus 5-fluorouracil. Ten characteristics were analyzed: Pre-radiotherapy hemoglobin, T-/N-category, Karnofsky performance-score (KPS), gender, age, chemotherapy type, tumor site, grading and radiation dose. Results: On multivariate analyses, hemoglobin 12-14 g/dl (p=0.040), lower T-category (p=0.010), lower N-category (p=0.042) and female gender (p=0.006) were predictive of LRC. Hemoglobin >12 g/dl (p=0.020), lower N-category (p<0.001), KPS ≥80 (p<0.001), female gender (p=0.024) and cisplatin 100 mg/m2 or 5×20 mg/m2 (p<0.001) were predictors of improved OS. Conclusion: Predictors of LRC and OS were identified that can improve personalization of treatment. Since chemotherapy type was associated with OS, studies comparing different regimens are warranted.",
keywords = "Definitive radio(chemo) therapy, Locally advanced SCCHN, Locoregional control, Overall survival, Prognostic factors",
author = "Daniel Seidl and Stefan Janssen and Primoz Strojan and Amira Bajrovic and Schild, {Steven E.} and Dirk Rades",
year = "2016",
language = "English (US)",
volume = "36",
pages = "2523--2526",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - Prognostic factors after definitive radio(chemo)therapy of locally advanced head and neck cancer

AU - Seidl, Daniel

AU - Janssen, Stefan

AU - Strojan, Primoz

AU - Bajrovic, Amira

AU - Schild, Steven E.

AU - Rades, Dirk

PY - 2016

Y1 - 2016

N2 - Aim: To identify predictors of locoregional control (LRC) and overall survival (OS) after definitive radio(chemo)therapy for squamous cell carcinoma of the head and neck (SCCHN). Patients and Methods: Two hundred and seventy-five patients were evaluated; 261 patients received radiochemotherapy with 30-40 mg/m2 of cisplatin weekly, three courses of cisplatin 100 mg/m2, two courses of cisplatin 5×20 mg/m2 or two courses of cisplatin 5×20 mg/m2plus 5-fluorouracil. Ten characteristics were analyzed: Pre-radiotherapy hemoglobin, T-/N-category, Karnofsky performance-score (KPS), gender, age, chemotherapy type, tumor site, grading and radiation dose. Results: On multivariate analyses, hemoglobin 12-14 g/dl (p=0.040), lower T-category (p=0.010), lower N-category (p=0.042) and female gender (p=0.006) were predictive of LRC. Hemoglobin >12 g/dl (p=0.020), lower N-category (p<0.001), KPS ≥80 (p<0.001), female gender (p=0.024) and cisplatin 100 mg/m2 or 5×20 mg/m2 (p<0.001) were predictors of improved OS. Conclusion: Predictors of LRC and OS were identified that can improve personalization of treatment. Since chemotherapy type was associated with OS, studies comparing different regimens are warranted.

AB - Aim: To identify predictors of locoregional control (LRC) and overall survival (OS) after definitive radio(chemo)therapy for squamous cell carcinoma of the head and neck (SCCHN). Patients and Methods: Two hundred and seventy-five patients were evaluated; 261 patients received radiochemotherapy with 30-40 mg/m2 of cisplatin weekly, three courses of cisplatin 100 mg/m2, two courses of cisplatin 5×20 mg/m2 or two courses of cisplatin 5×20 mg/m2plus 5-fluorouracil. Ten characteristics were analyzed: Pre-radiotherapy hemoglobin, T-/N-category, Karnofsky performance-score (KPS), gender, age, chemotherapy type, tumor site, grading and radiation dose. Results: On multivariate analyses, hemoglobin 12-14 g/dl (p=0.040), lower T-category (p=0.010), lower N-category (p=0.042) and female gender (p=0.006) were predictive of LRC. Hemoglobin >12 g/dl (p=0.020), lower N-category (p<0.001), KPS ≥80 (p<0.001), female gender (p=0.024) and cisplatin 100 mg/m2 or 5×20 mg/m2 (p<0.001) were predictors of improved OS. Conclusion: Predictors of LRC and OS were identified that can improve personalization of treatment. Since chemotherapy type was associated with OS, studies comparing different regimens are warranted.

KW - Definitive radio(chemo) therapy

KW - Locally advanced SCCHN

KW - Locoregional control

KW - Overall survival

KW - Prognostic factors

UR - http://www.scopus.com/inward/record.url?scp=85018710353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018710353&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 2523

EP - 2526

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5

ER -